{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:45:25Z","timestamp":1762001125940,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1746,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/modpathol.2017.159","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T07:41:10Z","timestamp":1510904470000},"page":"652-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-1967","authenticated-orcid":false,"given":"Naveena","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Faruqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1639-5003","authenticated-orcid":false,"given":"Michael","family":"Anglesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.159_bib1","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology 1","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocrine Rev"},{"key":"10.1038\/modpathol.2017.159_bib2","doi-asserted-by":"crossref","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2017.159_bib3","first-page":"1361","article-title":"BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis","volume":"60","author":"Schorge","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.159_bib4","first-page":"490","article-title":"Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum","volume":"55","author":"Muto","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.159_bib5","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/sj.onc.1201901","article-title":"Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum","volume":"16","author":"Bandera","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.159_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jnci\/90.11.841","article-title":"Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations","volume":"90","author":"Schorge","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2017.159_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","article-title":"Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series","volume":"39","author":"Morrison","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.12419","article-title":"Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal","volume":"65","author":"Singh","year":"2014","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.159_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAT.0000000000000291","article-title":"The secondary Mullerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters","volume":"47","author":"Singh","year":"2015","journal-title":"Pathology"},{"key":"10.1038\/modpathol.2017.159_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2017.159_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000270","article-title":"Adopting a uniform approach to site assignment in tubo-ovarian high-grade serous carcinoma: the time has come","volume":"35","author":"Singh","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2017.159_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.159_bib17","doi-asserted-by":"crossref","unstructured":"Singh N, Benson JL, Gan C et al. Disease distribution in low-stage tubo-ovarian high-grade serous carcinoma (HGSC): implications for assigning primary site and FIGO stage. Int J Gynecol Pathol; advance online publication, 29 April 2017; 10.1097\/PGP.0000000000000392 [e-pub ahead of print].","DOI":"10.26226\/morressier.578f37fdd462b8028d88f8dc"},{"key":"10.1038\/modpathol.2017.159_bib18","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-15-2233","article-title":"Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis","volume":"22","author":"McConechy","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.159_bib19","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2017.159_bib20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","article-title":"Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis","volume":"37","author":"Bijron","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high\u2010grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2017.159_bib22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2017.159_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2017.159_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"Kobel","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"10.1038\/modpathol.2017.159_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2017.159_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2867-7-2","article-title":"Clinical implications and utility of field cancerization","volume":"7","author":"Dakubo","year":"2007","journal-title":"Cancer Cell Int"},{"key":"10.1038\/modpathol.2017.159_bib27","first-page":"331","article-title":"Field effect in cancer-an update","volume":"39","author":"Chai","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1038\/modpathol.2017.159_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1038\/modpathol.2017.159_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1038\/modpathol.2017.159_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1038\/modpathol.2017.159_bib32","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/modpathol.2016.101","article-title":"CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma","volume":"29","author":"Kuhn","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.159_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.159_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2004.12.028","article-title":"Centrosome amplification, chromosome instability and cancer development","volume":"230","author":"Fukasawa","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.2017.159_bib35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ncb2345","article-title":"The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries","volume":"13","author":"Nigg","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1038\/modpathol.2017.159_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.159_bib38","doi-asserted-by":"crossref","unstructured":"Gurda GT, Serdy KM, Yatsenko SA et al. Synchronous bilateral tubal serous carcinomas in a patient with exon 13 duplication and loss of function of BRCA1. Int J Gynecol Pathol; advance online publication, 29 April 2017; 10.1097\/PGP.0000000000000392 [e-pub ahead of print].","DOI":"10.1097\/PGP.0000000000000392"},{"key":"10.1038\/modpathol.2017.159_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1038\/modpathol.2017.159_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000336","article-title":"The fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma: findings of a survey of pathologists and clinicians","volume":"36","author":"McCluggage","year":"2017","journal-title":"Int J Gynecol Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:39:47Z","timestamp":1760229587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0893395222007669"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.159","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2018.27","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}